Current Challenges in Gonorrhea Management: A Focus on Diagnosis, Treatment, and Antimicrobial Resistance

Gonorrhea, caused by Neisseria gonorrhoeae, remains the second most common bacterial sexually transmitted infection in the United States, with approximately 1.57 million new infections annually. The growing challenge of antimicrobial resistance (AMR) in N gonorrhoeae has led to critical screening and treatment guidelines advancements. This study provides a comprehensive review of gonorrhea's epidemiology, pathophysiology, and clinical manifestations. The study also highlights the role of expedited partner therapy and the need for enhanced patient education to prevent reinfection. The discussion emphasizes the importance of ongoing surveillance, updated clinical practices, and health education to combat the rising rates of gonorrhea and the spread of AMR.